Deoxynojirimycin hydrochloride

Independent reference data for Deoxynojirimycin hydrochloride (CAS 73285-50-4), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Pompe disease, also known as glycogen storage disease type II or acid maltase deficiency, is a relatively rare neuromuscular and lysosomal storage disorder caused by inherited genetic mutations in a key enzyme called α-glucosidase (Gaa).Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Synonyms and trade names

73285-50-4; 1-Deoxynojirimycin hydrochloride; Duvoglustat hydrochloride; Duvoglustat HCl; Moranoline hydrochloride; 0RN23C42QR; AT-2220; 1 Deoxynojirimycin Hydrochloride; 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3R,4R,5S)-; RefChem:136022; Deoxynojirimycin hydrochloride; (2R,3R,4R,5S)-2-(Hydroxymethyl)piperidine-3,4,5-triol hydrochloride; 1-Deoxy-L-altronojirimycin Hydrochloride; Moranoline HCl; AT2220; Duvoglustat hydrochloride [USAN]

GHS hazard classification

Reported hazard statements	H315 (100%), H319 (100%), H335 (100%)

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

What the public record says

Deoxynojirimycin hydrochloride · CAS 73285-50-4 · C6H14ClNO4. UNII 0RN23C42QR.

Source: PubChem / Wikidata; the batch COA governs where values differ.